Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends That Matter for the Healthcare Industry in 2017

Posted by Matt Breese on May 25, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is the state of the healthcare industry in 2017. 

This year, experts predict that pharma will play a bigger role in delivering value-based care. At the same time, the healthcare industry will continue to become more consumer focused and will see be more collaborations between payers and providers. Health IT companies may experience higher standards and longer sales cycles. Pharma companies will also strive to be more innovative to stay competitive. 

Read More

Topics: Industry Trends

Perspectives on Prescriber Personas

Posted by Matt Breese on May 23, 2017

Brand teams need to intimately understand who their prescribers are in order to reach the end goal of having prescribers write a script for their brand. Knowing the background and demographics of specific prescribers is critical for brand marketers to craft and deliver the right message at the right time.

Field teams need to be able to determine the physician “type” to create the optimal communication strategy. In addition, marketing teams need to be able to make sense out of these categories to optimize script opportunities.

Read More

Topics: Industry Trends, Market Access

Trends That Matter for Pharma Brands on Social Media

Posted by Matt Breese on May 18, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is the presence of pharmaceutical brands on social media channels. To provide accurate information directly to patients, being active online is beneficial for pharma companies.

Many patients today use social media as a way to obtain medical information and seek social support. However, pharma companies often shy away from using these channels due to the FDA's guidance on Internet and social media use.

Read More

Topics: Industry Trends, Branding & Marketing

MMIT Reality Check on Viscosupplements (May 2017)

Posted by Matt Breese on May 17, 2017

According to our recent payer coverage analysis for viscosupplements, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Perspectives on the Role of Market Access in Drug Launches

Posted by Matt Breese on May 16, 2017

Months before the first scripts are written, and long before revenue actuals are compared to sales forecasts, a launch brand’s market access future has largely been determined. Despite challenges, pharma teams need to begin employing market access strategies earlier in the drug development process.

It is important to consider market forecasting during pre-launch stages. Specifically, twenty-four months before commercial launch, pharma teams need to model evidence requirements that payers may use to determine their market access.

Read More

Topics: Market Access, Branding & Marketing

Trends That Matter for Prescription Pricing

Posted by Matt Breese on May 11, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is prescription pricing. 

According to Lydia Ramsey, Reporter at Business Insider, it typically takes five companies to bring a drug all the way from initial development to a patient's medicine cabinet.

Read More

Topics: Industry Trends

Perspectives on New to Market Policies

Posted by Matt Breese on May 10, 2017

One key component of launching a new drug into the market is understanding how payers and PBMs will cover the drug. Payers and PBMs establish new-to-market (NTM) policies to handle drug launches. To understand these coverage policies, brand marketers can either look at analog data of drug launches from similar situations in other disease areas or review historical data for their specific class.

This step helps brand teams select where to promote or contract with payers for better access. This process also helps pharma predict and prepare for the first 90, 120 and 180 days post launch. 

Read More

Topics: Market Access, Branding & Marketing

Perspectives on Getting New Drugs to Market

Posted by Matt Breese on May 8, 2017

Introducing new drugs, small molecules and biologics to the U.S. market expands patient treatment options, gives consumers greater choice, and encourages healthcare innovation. However, getting a new pharmaceutical drug approved and into the market is a lengthy and expensive process. According to Medicine Net:

“It takes an average of 12 years for an experimental drug to travel from the laboratory to your medicine cabinet. That is, if it makes it. Only 5 in 5,000 drugs that enter preclinical testing progress to human testing. One of these 5 drugs that are tested in people is approved. The chance for a new drug to actually make it to market is thus only 1 in 5,000.” 

Read More

Topics: Industry Trends, Market Access

MMIT Reality Check on Respiratory (Asthma/COPD) (May 2017)

Posted by Matt Breese on May 5, 2017

According to our recent payer coverage analysis for asthma and COPD treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Branding & Marketing

Trends That Matter for Biomarker Research

Posted by Matt Breese on May 2, 2017

In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is biomarker research and development. Biomarkers are used to monitor health status, detect conditions, and select the most effective treatment options. In the pharma industry, biomarkers are also used to determine the safety and effectiveness of drugs based on overall population data and individual patient information. 

As biomarker research expands and data access improves, clinicians will have greater ability to deliver personalized care, contributing to the value-based care shift. According to biochemistry research by Timothy J. Hagen and Northern Illinois University

Read More

Topics: Industry Trends, Data & Analytics